Association of Nadir PSA >0.5ng/Ml after Dose Escalated External Beam Radiation With Prostate Cancer-Specific Endpoints

被引：0
|
作者：
Sheth, N. [1 ,2 ]
Osborn, V. W. [1 ,2 ]
Lee, A. [1 ,2 ]
Schwartz, D. [2 ]
Schreiber, D. [2 ]
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] Vet Affairs NY Harbor Healthcare Syst, Brooklyn, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2632
引用
收藏
页码：E264 / E265
页数：2
相关论文
共 50 条
  • [1] Association of Nadir Prostate-specific Antigen > 0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints
    Sheth, Niki
    Youssef, Irini
    Osborn, Virginia
    Lee, Anna
    Safdieh, Joseph
    Schreiber, David
    CUREUS, 2018, 10 (06):
  • [2] PSA of 0.5 ng/mL or less and prostate cancer radiation
    Anscher, MS
    UROLOGY, 1998, 52 (03) : 531 - 531
  • [3] The predictive value of PSA nadir and time to nadir after external beam radiation for prostate cancer
    Chandra, A
    Levy, LB
    Kuban, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S439 - S440
  • [4] A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL is clinically significant after external beam radiotherapy for prostate cancer
    Feigenberg, Steven J.
    Hanlon, Alexandra L.
    Horwitz, Eric M.
    Uzzo, Robert G.
    Eisenberg, Debra
    Pollack, Alan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 458 - 462
  • [5] Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer
    Pinover, WH
    Hanlon, AL
    Horwiltz, EM
    Hanks, GE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03): : 649 - 654
  • [6] EXTREME-RISK PROSTATE ADENOCARCINOMA PRESENTING WITH PROSTATE-SPECIFIC ANTIGEN (PSA) >40 NG/ML: PROGNOSTIC SIGNIFICANCE OF THE PRERADIATION PSA NADIR
    Alexander, Abraham S.
    Mydin, Aminudin
    Jones, Stuart O.
    Christie, Jennifer
    Lim, Jan T. W.
    Truong, Pauline T.
    Ludgate, Charles M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E713 - E719
  • [7] Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients
    Romesser, Paul B.
    Pei, Xin
    Shi, Weiji
    Zhang, Zhigang
    Kollmeier, Marisa
    McBride, Sean M.
    Zelefsky, Michael J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 59 - 67
  • [8] PSA nadir predicts biochemical recurrence after external beam radiation therapy combined to high dose rate brachytherapy in the treatment of prostate cancer
    Coelho, Marcos O. S.
    Dal Col, Luciana S. B.
    Capibaribe, Diego M.
    Salgado, Carla M.
    Travassos, Thiago C.
    Vanderlei, J., Jr.
    Monti, Carlos R.
    Reis, Leonardo O.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (01): : 52 - 62
  • [9] PSA nadir ≤4ng/ml within 4 months after External Radiotherapy and Brachytherapy of prostate cancer as a new indicator for outcome
    Nickers, P
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S27 - S27
  • [10] Prostate-specific antigen (PSA) in the monitoring of prostate cancer after radical prostatectomy and external beam radiation
    Schaefer, U
    Witt, F
    Schueller, P
    Micke, O
    Willich, N
    ANTICANCER RESEARCH, 2000, 20 (6D) : 4989 - 4992
12345